GTEx Donors Hold Promise of Hope
LifeGift is among a handful of recovery agencies across the country participating in the National Institutes of Health (NIH) Genotype-Tissue Expression (GTEx) project, aimed at increasing the understanding of how changes in genes affect human health and disease. The project benefits the community through an expanded knowledge of the complex patterns of genetic variation across a broad range of tissue types, offering hope for the health care of future generations.
To date, LifeGift has recovered eight GTEx donors.
“The benefits of this project will be realized for over a decade, making it a top priority for the NIH,” said Brian Roe, managing director of tissue operations and donor resource operations. “This is significant work from a public health perspective and will provide many insights to understanding the relationship between genetic variation and gene expression in human tissue.”